Implantica AG reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 0.596 million compared to EUR 0.307 million a year ago. Net loss was EUR 3.36 million compared to EUR 4.55 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.65 SEK | -1.44% |
|
+14.09% | +57.53% |
Jun. 19 | Implantica Announces Further Expansion of Refluxstop? Access in the Uk Nhs Public Hospital Network | CI |
May. 15 | Transcript : Implantica AG, Q1 2024 Earnings Call, May 15, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.53% | 1.02B | |
+75.69% | 12.57B | |
-28.01% | 7.02B | |
-2.09% | 6.09B | |
+10.01% | 5.24B | |
-18.23% | 4.76B | |
+15.57% | 4.11B | |
-20.84% | 2.99B | |
-1.24% | 2B | |
+12.39% | 1.81B |
- Stock Market
- Equities
- IMP A SDB Stock
- News Implantica AG
- Implantica AG Reports Earnings Results for the First Quarter Ended March 31, 2024